New program aims to ease menopause after cancer

NCT ID NCT06982677

First seen May 14, 2026 · Last updated Jun 20, 2026 · Updated 6 times

Summary

This study is creating and testing a nurse-led program for women who go through early menopause after cancer treatment. The program includes education, decision support, and skills to manage menopause symptoms. Researchers want to see if the program is easy to use and helpful for participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke Cancer Institute

    RECRUITING

    Durham, North Carolina, 27705, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Nurse Navigator Intervention (behavioral program with education, decision support, and symptom management skills)

What this could lead to

If it works, this could provide a practical, supportive program to help women better manage early menopause symptoms after cancer treatment.

What could go wrong

This is a small, early-stage pilot study focused on feasibility and acceptability, not on proving the program works. It may not show clear benefits or be generalizable to all women.

Conditions

The condition(s) this trial relates to.

neoplasm premature menopause primary ovarian failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.